secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001493152-23-029441
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.08
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa CSO retiring Aug 18; annual meeting Oct 31, proposal deadline Aug 30
----------------------------------------------------------------------------

- CSO Nicholas A. LaBella, Jr. notified planned retirement effective August 18, 2023.
- He is expected to remain as a member of the Scientific Advisory Board post-retirement.
- Company will enter a separation agreement for compensation related to his departure.
- 2023 annual meeting of stockholders set for Tuesday, October 31, 2023.
- Deadline for stockholder proposals and director nominations is August 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223029441/0001493152-23-029441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223029441/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-029441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer